Heart device clot risk: study tests which blood thinner works best
NCT ID NCT03568890
Summary
This study aims to find the best short-term medication to prevent blood clots from forming on a heart device. The device is implanted to help prevent strokes in people with atrial fibrillation. Researchers are comparing a newer type of blood thinner (DOAC) to standard aspirin-like therapy for 60 days after the procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Josep Rodes-Cabau
Québec, Quebec, G1V 4G5, Canada
Conditions
Explore the condition pages connected to this study.